Ultracell raises $3.8M for portable fuel cells
UltraCell, provider of fuel cells for mobile applications, has brought in $3.8 million in capital, according to VentureWire. BASF Venture Capital, OnPoint Technologies, Espirito Santo Ventures and Miami Valley Venture Fund led the round. Based in Livermore, Calif. the company has raised $30 million in… Continue Reading
PowerGenix gets $30M for electric scooter batteries
Alt-chemistry battery maker PowerGenix has significantly upped its funding with a $30 million fourth round. The company plans to make batteries for electric vehicles, power tools, electronics and other applications.
One of PowerGenix’s most ambitious plans is to crack into the market for electric scooters, which… Continue Reading
PowerGenix hopes to overtake NiMH dominance with alt-chemistry rechargeable batteries
With the market for hybrid electric vehicles (HEVs) finally starting to heat up in earnest, several companies are making big bets on advanced rechargeable battery technologies. One of these is PowerGenix, a San Diego, Calif.-based startup that makes nickel-zinc (NiZn) batteries.
Another is ZPower, a startup… Continue Reading
Will lithium ion get replaced? Longer lasting, recyclable batteries due in laptops this summer
Lithium ion technology batteries have been on the market for over 16 years now, and like a human of the same age, the technology’s growth appears to be slowing. Improvements in the battery technology are lessening each year, and the power demand from electronics, fueled… Continue Reading
Akermin raises $5M for fuel-cell bioenzymes
NOTE: This item also appears in Monday’s daily briefing at VentureBeat Life Sciences.
Akermin, a St. Louis developer of new biocatalytic enzymes, raised $5 million in a second tranche of its first funding round. Investors included Prolog Ventures, OnPoint Technologies, Chrysalix Energy and the St. Louis Arch… Continue Reading
Life sciences briefing: Tuesday, Nov. 13, 2007
Featured companies: Akermin, Fluxion Biosciences, iCardiacTechnologies, Wellocities
UPDATED: Expanded items on Fluxion, Akermin, and Wellocities.
Fluxion Bio draws in $6.9M for cell-analysis tools — Fluxion Biosciences, a San Francisco developer of cellular-analysis tools, raised $6.9 million in a second funding round, VentureWire reports (subscription required). Investors included Kodiak Venture… Continue Reading